Numeta G13%E

· Baxter Healthcare Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Numeta G13%E, covering 2013-09-20 to 2025-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Numeta G13%E Compared to Compounded Parenteral Nutrition in Preterm Neonates [Phase 3]